These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 33288309

  • 1. Living Donor Liver Transplantation Versus Deceased Donor Liver Transplantation for Hepatocellular Carcinoma Within or Beyond the Milan Criteria: Comparable Long-Term Outcomes.
    Lee S, Song GW, Kim KW, Kwon JH, Lee SG.
    Transplant Proc; 2021; 53(1):92-97. PubMed ID: 33288309
    [Abstract] [Full Text] [Related]

  • 2. Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation.
    Xiao GQ, Song JL, Shen S, Yang JY, Yan LN.
    World J Gastroenterol; 2014 Aug 21; 20(31):10953-9. PubMed ID: 25152599
    [Abstract] [Full Text] [Related]

  • 3. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis.
    Liang W, Wu L, Ling X, Schroder PM, Ju W, Wang D, Shang Y, Kong Y, Guo Z, He X.
    Liver Transpl; 2012 Oct 21; 18(10):1226-36. PubMed ID: 22685095
    [Abstract] [Full Text] [Related]

  • 4. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
    Park MS, Lee KW, Suh SW, You T, Choi Y, Kim H, Hong G, Yi NJ, Kwon CH, Joh JW, Lee SK, Suh KS.
    Transplantation; 2014 Jan 15; 97(1):71-7. PubMed ID: 24056623
    [Abstract] [Full Text] [Related]

  • 5. Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses.
    Wong TCL, Ng KKC, Fung JYY, Chan AAC, Cheung TT, Chok KSH, Dai JWC, Lo CM.
    Ann Surg Oncol; 2019 May 15; 26(5):1454-1462. PubMed ID: 30737669
    [Abstract] [Full Text] [Related]

  • 6. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
    Lee EC, Kim SH, Shim JR, Park SJ.
    Liver Transpl; 2018 Jan 15; 24(1):35-43. PubMed ID: 28885774
    [Abstract] [Full Text] [Related]

  • 7. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence.
    Sandhu L, Sandroussi C, Guba M, Selzner M, Ghanekar A, Cattral MS, McGilvray ID, Levy G, Greig PD, Renner EL, Grant DR.
    Liver Transpl; 2012 Mar 15; 18(3):315-22. PubMed ID: 22140013
    [Abstract] [Full Text] [Related]

  • 8. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma.
    Ninomiya M, Shirabe K, Facciuto ME, Schwartz ME, Florman SS, Yoshizumi T, Harimoto N, Ikegami T, Uchiyama H, Maehara Y.
    J Am Coll Surg; 2015 Mar 15; 220(3):297-304.e3. PubMed ID: 25617912
    [Abstract] [Full Text] [Related]

  • 9. Living-donor or deceased-donor liver transplantation for hepatic carcinoma: a case-matched comparison.
    Wan P, Zhang JJ, Li QG, Xu N, Zhang M, Chen XS, Han LZ, Xia Q.
    World J Gastroenterol; 2014 Apr 21; 20(15):4393-400. PubMed ID: 24764678
    [Abstract] [Full Text] [Related]

  • 10. Living donor liver transplantation for hepatocellular carcinoma: long-term results compared with deceased donor liver transplantation.
    Di Sandro S, Slim AO, Giacomoni A, Lauterio A, Mangoni I, Aseni P, Pirotta V, Aldumour A, Mihaylov P, De Carlis L.
    Transplant Proc; 2009 May 21; 41(4):1283-5. PubMed ID: 19460539
    [Abstract] [Full Text] [Related]

  • 11. Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation.
    Bhangui P, Vibert E, Majno P, Salloum C, Andreani P, Zocrato J, Ichai P, Saliba F, Adam R, Castaing D, Azoulay D.
    Hepatology; 2011 May 21; 53(5):1570-9. PubMed ID: 21520172
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the outcomes of patients who underwent deceased-donor or living-donor liver transplantation after successful downstaging therapy.
    Lei J, Yan L, Wang W.
    Eur J Gastroenterol Hepatol; 2013 Nov 21; 25(11):1340-6. PubMed ID: 23652915
    [Abstract] [Full Text] [Related]

  • 13. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
    Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J.
    Br J Surg; 2007 Jan 21; 94(1):78-86. PubMed ID: 17016793
    [Abstract] [Full Text] [Related]

  • 14. Can living donor liver transplantation offer similar outcomes to deceased donor liver transplantation using expanded selection criteria for hepatocellular carcinoma?
    Chen LP, Li C, Wen TF, Yan LN, Li B, Yang JY.
    Pak J Med Sci; 2015 Jan 21; 31(4):763-9. PubMed ID: 26430399
    [Abstract] [Full Text] [Related]

  • 15. Liver transplantation for hepatocellular carcinoma: Korean experience.
    Lee S, Ahn C, Ha T, Moon D, Choi K, Song G, Chung D, Park G, Yu Y, Choi N, Kim K, Kim K, Hwang S.
    J Hepatobiliary Pancreat Sci; 2010 Sep 21; 17(5):539-47. PubMed ID: 19727542
    [Abstract] [Full Text] [Related]

  • 16. Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria.
    Jiang L, Liao A, Wen T, Yan L, Li B, Yang J.
    Transpl Int; 2014 Jun 21; 27(6):562-9. PubMed ID: 24606007
    [Abstract] [Full Text] [Related]

  • 17. Clinical outcomes and risk factors of hepatocellular carcinoma treated by liver transplantation: A multi-centre comparison of living donor and deceased donor transplantation.
    Hu Z, Qian Z, Wu J, Zhou J, Zhang M, Zhou L, Zheng S.
    Clin Res Hepatol Gastroenterol; 2016 Jun 21; 40(3):315-326. PubMed ID: 26382281
    [Abstract] [Full Text] [Related]

  • 18. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
    Lee KW, Yi NJ, Suh KS.
    Transplantation; 2014 Apr 27; 97 Suppl 8():S20-3. PubMed ID: 24849825
    [Abstract] [Full Text] [Related]

  • 19. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
    Yoon YI, Song GW, Lee SG, Hwang S, Kim KH, Kim SH, Kang WH, Cho HD, Jwa EK, Kwon JH, Tak EY, Kirchner VA.
    J Hepatol; 2018 Jun 27; 68(6):1153-1162. PubMed ID: 29452208
    [Abstract] [Full Text] [Related]

  • 20. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
    Jain A, Singhal A, Kashyap R, Safadjou S, Ryan CK, Orloff MS.
    Transplantation; 2011 Aug 27; 92(4):453-60. PubMed ID: 21799468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.